Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02750228 · ClinicalTrials.gov registry record
PDA Post NICU Discharge
A clinical trial, sponsored by Pediatrix.
- Completed
- Registry status
- 208
- Enrollment target
NCT02750228 is a clinical trial that has completed, run by Pediatrix. The registered enrollment target is 208 participants.
The verdict
NCT02750228 has completed, sponsored by Pediatrix.
- COMPLETED
- Registry status
- 208 participants
- Enrollment target
Study Summary
The purpose of this study is to track post-discharge outcomes on prematurely born infants who are discharged from the NICU with a patent ductus arteriosus (PDA). Investigators plan to report on the spontaneous closure rate as well as the incidence of pulmonary and/or cardiac events in these infants. The goal is to identify risk factors associated with adverse outcomes in prematurely born infants who are sent home with a PDA.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2016-05 |
| Est. Completion | 2020-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02750228
The ClinicalTrials.gov registry entry for NCT02750228 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pediatrix, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02750228 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02750228 about?
NCT02750228 is a clinical study titled "PDA Post NICU Discharge". The purpose of this study is to track post-discharge outcomes on prematurely born infants who are discharged from the NICU with a patent ductus arteriosus (PDA). Investigators plan to report on the spontaneous closure rate as well as the incidence of pulmonary and/or cardiac events in these infants....
What is the current status of trial NCT02750228?
This trial is currently completed. The enrollment target is 208 participants. The study started on 2016-05. Estimated completion is 2020-06-30.
Who is sponsoring clinical trial NCT02750228?
This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.